Announcements Trials
Browse Landscape

Phase

Phase 2 67Phase 3 31Phase 1 20Phase 1/2 18Phase 4 3Phase NA 2Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Triple Negative Breast Neoplasms 7Breast Neoplasms 6Lung Neoplasms 5Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Endometrial Neoplasms 3Carcinoma, Ovarian Epithelial 3Neoplasms 2Medulloblastoma 2Fallopian Tube Neoplasms 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Urethral Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thymoma 1Thymic epithelial tumor 1Thrombocythemia, Essential 1Stage IIIB or IV Non-Small Cell Lung Cancer 1Squamous NSCLC 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Retinoblastoma 1Recurrence 1Primary Myelofibrosis 1Primary Malignant Neoplasm of Ovary 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Topotecan 2Drug Therapy 2sintilimab 1dinutuximab 1atezolizumab 1Temozolomide 1SR 48692 1Rabeprazole 1Irinotecan 1Etoposide 1Electroporation 1EC regimen 1E-3810 1Cryosurgery 1Carboplatin 1Bevacizumab 12,2',4,4',5-pentachlorodiphenyl ether 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Small Cell Lung Carcinoma × Carboplatin × Clear all
NCT00168896 2006-02-14

A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Charite University, Berlin, Germany

Phase 2/3 Unknown
286 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡